Options: Show MedDRA Preferred Terms, display all 21 labels
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood glucose decreased | x | x | x | x | x | x | ||||||||||||||||
| Diabetes mellitus | x | x | x | x | ||||||||||||||||||
| Diabetic | x | x | x | x | x | x | ||||||||||||||||
| Diabetic retinopathy | x | x | ||||||||||||||||||||
| Glucose-6-phosphate dehydrogenase deficiency | x | |||||||||||||||||||||
| Hyperglycaemia | x | x | x | x | x | x | ||||||||||||||||
| Ketosis | x | |||||||||||||||||||||
| Nephropathy | x | x | ||||||||||||||||||||
| Neuropathy | x | x | ||||||||||||||||||||
| Obesity | x | x | x | x | x | x | ||||||||||||||||
| Type 1 diabetes mellitus | x | x | ||||||||||||||||||||
| Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Weight decreased | x | x | x | x | x | x | x | |||||||||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |